Synthesis and pharmacological characterization of β2- adrenergic agonist enantiomers: Zilpaterol

Journal of Medicinal Chemistry

Volumn 52, Issue 6, 2009, Pages 1773-1777

  Kern, Christopher ^a   Meyer, Thorsten ^a   Droux, Serge ^b   Schollmeyer, Dieter ^c   Miculka, Christian ^a,d  

^a Intervet Innovation GmbH   (Germany)

^b Mutabilis Parc Biocitech   (France)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; ZILPATEROL;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; GUINEA PIG; NONHUMAN; X RAY CRYSTALLOGRAPHY;

ADRENERGIC BETA-AGONISTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLOGRAPHY, X-RAY; HUMANS; RECEPTORS, ADRENERGIC, BETA-2; RECOMBINANT PROTEINS; STEREOISOMERISM; TRIMETHYLSILYL COMPOUNDS;

EID: 64349084026     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm801211c     Document Type: Article

References (25)

1. Barnes, P. J. Beta-adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med. 1995, 152, 838-860.
2. Broadley, K. J. β-Adrenoceptor responses of the airways: for better or worse? Eur.J. Parmacol. 2006, 533, 15-27.
3. Hagstrom-Toft, E.; Enoksson, S.; Moberg, E.; Bolinder, J.; Arner, P. β-Adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo. Am. J. Physiol. 1998, 275, E909-E916.
4. Mersmann, H. J. Overview of the effects of β-adrenergic receptor agonists on animal growth including mechanisms of action. J. Anim. Sci. 1998, 76, 160-172.
5. U.S. Food and Drug Administration, Center for Veterinary Medicine. NADA 141-258 Zilmax (Zilpaterol Hydrochloride) Type A Medicated Article for Cattle Fed in Confinement for Slaughter. http://www.fda.gov/cvm/FOI/141-258o08102006. pdf (accessed Nov 10, 2008).
6. Handley, D. The asthma-like pharmacology and toxicology of (S)-isomers of β-agonists. J. Allergy Clin. Immunol. 1999, 104, S69-S76.
7. 2-Agonist eutomers: A rational option for the treatment of asthma? Am. J. Respir. Med. 2002, 1 (5), 305-311.
8. Handley, D. A.; Morley, J.; Vaickus, L. Levalbuterol hydrochloride. Expert Opin. Invest. Drugs 1998, 7, 2027-2041.
9. Schreck, D. M.; Babin, S. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED. Am. J. Emerg. Med. 2005, 23, 842-847.
10. Agranat, I.; Caner, H.; Caldwell, J. Putting chirality to work: the strategy of chiral switches. Nat. Rev. Drug Discovery 2002, 1, 753-768.
11. 2-selective adrenoceptor antagonist (ICI 118,551). J. Cardiovasc. Pharmacol. 1983, 5, 430-437.
12. Rensch, H.; Renovanz, H. D. Clenbuterol: review of a new broncholytic agent. Med. Monatsschr. 1977, 31, 457-460.
13. Ricke, E. A.; Smith, D. J.; Feil, V. J.; Larsen, G. L.; Caton, J. S. Effects of ractopamine HCl stereoisomers on growth, nitrogen retention, and carcass composition in rats. J. Anim. Sci. 1999, 77, 701-707.
14. 3 adrenoceptors. Br. J. Pharmacol. 2005, 144, 317-322.
15. Mills, S. E.; Kissel, J.; Bidwell, C. A.; Smith, D. J. Stereoselectivity of porcine β-adrenergic receptors for ractopamine stereoisomers. J. Anim. Sci. 2003, 81, 122-129.
16. 2-adrenergic receptors. Clin. Rev. Allergy Immunol. 1996, 14, 37-45.
17. Spurlock, M. E.; Cusumano, J. C.; Mills, S. E. The affinity of ractopamine, clenbuterol, and L-644,969 for the fi-adrenergic receptor population in porcine adipose tissue and skeletal muscle membrane. J. Anim. Sci. 1993, 71, 2061-2065.
18. 2 values on guinea-pig trachea and atria. Naunyn-Schmiedeberg's Arch. Pharmacol. 1979, 308, 183-190.
19. Fichna, J.; Gach, K.; Piestrzeniewicz, M.; Burgeon, E.; Poels, J.; Broeck, J. V.; Janecka, A. Functional characterization of opioid receptor ligands by aequorin luminescence-based calcium assay. J. Pharmacol. Exp. Ther. 2006, 317, 1150-1154.
20. Le Poul, E.; Hisada, S.; Mizuguchi, Y.; Dupriez, V. J.; Burgeon, E.; Detheux, M. Adaptation of aequorin functional assay to high throughput screening. J. Biomol. Screening 2002, 7, 57-65.
21. Miculka, C.; Meyer, T.; Kern, C.; Droux, S. Zilpaterol Enantiomer Compositions and Methods of Making and Using Such Compositions. International Patent Application PCT/EP2007/057036, 2007.
22. 1-adrenoceptors and interaction with beta-blockers. Naunyn-Schmiede-berg's Arch. Pharmacol. 2004, 369, 525-532.
23. 2-adrenergic receptors. Cardiovasc. Drugs Ther. 1999, 13, 123-126.
24. Wang, J. B.; Johnson, P. S.; Persico, A. M.; Hawkins, A. L.; Griffin, C. A.; Uhl, G. R. Human μ-opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 1994, 338, 217-222.
25. Dubuis, S.; Krebs, O. Process for Making Zilpaterol and Salts Thereof. International Patent Application PCT/EP2008/053711, 2008.